Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake
about
High LRRK2 levels fail to induce or exacerbate neuronal alpha-synucleinopathy in mouse brainProgressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in miceParkinson's disease: animal models and dopaminergic cell vulnerabilityTransgenic LRRK2 (R1441G) rats-a model for Parkinson disease?Conditional expression of Parkinson's disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegenerationCognitive dysfunction and depression in Parkinson's disease: what can be learned from rodent models?Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging.LRRK2 affects vesicle trafficking, neurotransmitter extracellular level and membrane receptor localization.Selective expression of Parkinson's disease-related Leucine-rich repeat kinase 2 G2019S missense mutation in midbrain dopaminergic neurons impairs dopamine release and dopaminergic gene expression.Small molecule kinase inhibitors for LRRK2 and their application to Parkinson's disease models.The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalitiesExpression of human E46K-mutated α-synuclein in BAC-transgenic rats replicates early-stage Parkinson's disease features and enhances vulnerability to mitochondrial impairment.LRRK2 BAC transgenic rats develop progressive, L-DOPA-responsive motor impairment, and deficits in dopamine circuit functionHuman dopamine transporter gene: differential regulation of 18-kb haplotypesThe function of orthologues of the human Parkinson's disease gene LRRK2 across species: implications for disease modelling in preclinical research.Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice.Leucine-rich repeat kinase 2 (LRRK2) cellular biology: a review of recent advances in identifying physiological substrates and cellular functions.Insights into LRRK2 function and dysfunction from transgenic and knockout rodent models.LRRK2 and vesicle trafficking.LRRK2, a puzzling protein: insights into Parkinson's disease pathogenesisCellular processes associated with LRRK2 function and dysfunctionModels of LRRK2-Associated Parkinson's Disease.Genetic rat models of Parkinson's disease.LRRK2 R1441G mice are more liable to dopamine depletion and locomotor inactivity.Targeted kinase inhibition relieves slowness and tremor in a Drosophila model of LRRK2 Parkinson's disease.New developments in genetic rat models of Parkinson's disease.Dopamine D2 receptor-mediated neuroprotection in a G2019S Lrrk2 genetic model of Parkinson's disease.
P2860
Q27303568-215C7DEE-026D-4DAC-97C6-19B47CA0BCC2Q27308060-504D79A4-52C2-422C-A291-36E86077BCA1Q28080503-6A06CC0E-D500-4316-AA26-EEF79600B601Q30410927-2DD07BC4-2C25-4B9F-A3F4-F614FA8C25D1Q30653185-88372F26-59D6-48AB-B072-B37E0A871EB7Q34307633-F98E9705-84AB-484F-BD34-FE5385E2E4B6Q34325540-DF7D13A4-7EE0-4469-A9C6-FAF647A0C955Q35027709-A18814F7-4B3F-448E-AB49-4AFAAF035A84Q35999331-89CC8A0E-9FB0-457C-A83F-B55B24384A5AQ36015579-2FA9737F-E068-4E87-A7DD-2380513290F0Q36305967-ED54B371-1094-42BD-859A-872C878827CCQ36553302-65065FB7-FD75-4250-B2F9-346E6A1CCDABQ36581417-6A2CB0E6-FB71-46A0-98F4-7A2DFAB19657Q37408178-476DE36E-56FF-42E7-934D-B8A385F245AFQ37513500-4A47E9EE-6BB6-45BD-B8AF-08AABC85CA27Q37701053-13A17073-C35A-4AB0-AFB9-03AED663793BQ37955275-CC3659A3-408B-435A-BA46-21AF3DDE42D7Q38044434-23E2D8BB-75C0-4E8A-A849-FCDF43A33AA7Q38044441-5582F82E-ADD7-414E-ABF8-813FE041BF90Q38218398-3159ACFB-2015-41CF-9B29-D86BD57A9FBBQ38433725-BB19B63A-3E72-492B-A54E-2BA59B784080Q39206443-1525C623-3D45-4A43-BF04-E4DEBAC8E7D6Q42542683-C82DF0E0-855C-4A63-82BD-02F6A232F0D2Q42927984-2840C720-EB3F-47EC-9058-AEE2FDCB162CQ48163602-28A5782E-BD10-4DE3-B28D-2E51D975F9C5Q48502440-F1F3F501-8658-4365-9ECC-2735A380FC3DQ50055669-5121AB01-E0C3-4256-A025-66FAD4BB7CEE
P2860
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake
@ast
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake
@en
type
label
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake
@ast
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake
@en
prefLabel
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake
@ast
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake
@en
P2093
P2860
P356
P1476
Temporal expression of mutant LRRK2 in adult rats impairs dopamine reuptake
@en
P2093
Hongxia Zhou
Jianbin Tong
Weimin C Hong
Xu-Gang Xia
Yong-Jian Liu
P2860
P304
P356
10.7150/IJBS.7.753
P407
P50
P577
2011-06-09T00:00:00Z